Creation of a metabolic monitoring program for second-generation (atypical) antipsychotics.
Second-generation or ''atypical'' antipsychotics can cause metabolic derangements that lead to diabetes and cardiovascular disease. To potentially minimize these adverse effects, the University of Medicine and Dentistry of New Jersey - University Correctional HealthCare (UCHC) and the New Jersey Department of Corrections (NJ DOC) created a metabolic monitoring program that was incorporated into the electronic medical record. This program is used statewide by UCHC psychiatrists working within the NJ DOC.
Reeves
Rusty
R
University Correctional HealthCare, University of Medicine and Dentistry of New Jersey, Trenton, New Jersey 08625, USA. reevesdo@umdnj.edu
Kaldany
Herbert
H
Lieberman
Jordan
J
Vyas
Rajiv
R
D014150:Antipsychotic Agents / Q000009:adverse effects*; D016903:Drug Monitoring; D006801:Humans; D016347:Medical Records Systems, Computerized; D024821:Metabolic Syndrome / Q000209:etiology / Q000517:prevention & control*; D011330:Prisons
D014150:Antipsychotic Agents